[
  {
    "ts": null,
    "headline": "Stocks to Watch Wednesday Recap: Netflix, Schwab, J&J, United Airlines",
    "summary": "↘️ Netflix (NFLX): The streaming company posted better-than-expected quarterly results, but its cash flow and outlook disappointed, as did the news that it would pause buybacks. The stock dropped 2.2%.",
    "url": "https://finnhub.io/api/news?id=57f7fb58e6f5b7e2b7f2c0962e5f621b9538e01237367a4e890ca7c4ff583bbd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769032818,
      "headline": "Stocks to Watch Wednesday Recap: Netflix, Schwab, J&J, United Airlines",
      "id": 138199575,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "↘️ Netflix (NFLX): The streaming company posted better-than-expected quarterly results, but its cash flow and outlook disappointed, as did the news that it would pause buybacks. The stock dropped 2.2%.",
      "url": "https://finnhub.io/api/news?id=57f7fb58e6f5b7e2b7f2c0962e5f621b9538e01237367a4e890ca7c4ff583bbd"
    }
  },
  {
    "ts": null,
    "headline": "Alvotech: Why FDA Delays Don't Break The Bull Case",
    "summary": "Alvotech has five approved drugs, including biosimilars of AbbVie's Humira, Johnson & Johnson's Stelara/Simponi, and Eylea. See why ALVO stock is a Strong Buy.",
    "url": "https://finnhub.io/api/news?id=37cb85cba880bde7dbd1e2759d21fcf2c7efcf23e1ff29fe3d128d489296803e",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769031286,
      "headline": "Alvotech: Why FDA Delays Don't Break The Bull Case",
      "id": 138200440,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2159194981/image_2159194981.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "Alvotech has five approved drugs, including biosimilars of AbbVie's Humira, Johnson & Johnson's Stelara/Simponi, and Eylea. See why ALVO stock is a Strong Buy.",
      "url": "https://finnhub.io/api/news?id=37cb85cba880bde7dbd1e2759d21fcf2c7efcf23e1ff29fe3d128d489296803e"
    }
  },
  {
    "ts": null,
    "headline": "NEW YORK MARKET CLOSE: Shares up on Huang speech, US-Greenland deal",
    "summary": "NEW YORK MARKET CLOSE: Shares up on Huang speech, US-Greenland deal",
    "url": "https://finnhub.io/api/news?id=783682ba8ada66524a4a4f0b2cc1338a1f7b60e435bbed058d77a197d9459671",
    "source": "Fintel",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769031023,
      "headline": "NEW YORK MARKET CLOSE: Shares up on Huang speech, US-Greenland deal",
      "id": 138198791,
      "image": "",
      "related": "JNJ",
      "source": "Fintel",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=783682ba8ada66524a4a4f0b2cc1338a1f7b60e435bbed058d77a197d9459671"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson (JNJ) Reports Q4 Earnings: What Key Metrics Have to Say",
    "summary": "While the top- and bottom-line numbers for Johnson & Johnson (JNJ) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.",
    "url": "https://finnhub.io/api/news?id=ac2baf347111cf721dcfb90bdb4a70031580fe28793e2f392b7cc1421ed82e6e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769031003,
      "headline": "Johnson & Johnson (JNJ) Reports Q4 Earnings: What Key Metrics Have to Say",
      "id": 138199576,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "While the top- and bottom-line numbers for Johnson & Johnson (JNJ) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.",
      "url": "https://finnhub.io/api/news?id=ac2baf347111cf721dcfb90bdb4a70031580fe28793e2f392b7cc1421ed82e6e"
    }
  },
  {
    "ts": null,
    "headline": "Earnings live: Netflix stock tumbles, Johnson & Johnson falls, Charles Schwab climbs",
    "summary": "A broader set of sectors will be represented when 35 more S&P 500 companies report earnings this week, including Netflix, Procter & Gamble, and Intel.",
    "url": "https://finnhub.io/api/news?id=6df3e32284971202a832374159a3b63a44ef67b42b5162ec9bb98d466bc7d64f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769030791,
      "headline": "Earnings live: Netflix stock tumbles, Johnson & Johnson falls, Charles Schwab climbs",
      "id": 138198922,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "A broader set of sectors will be represented when 35 more S&P 500 companies report earnings this week, including Netflix, Procter & Gamble, and Intel.",
      "url": "https://finnhub.io/api/news?id=6df3e32284971202a832374159a3b63a44ef67b42b5162ec9bb98d466bc7d64f"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson (JNJ) Tops Q4 Earnings and Revenue Estimates",
    "summary": "Johnson & Johnson (JNJ) delivered earnings and revenue surprises of +1.05% and +1.84%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?",
    "url": "https://finnhub.io/api/news?id=5d22bb60448219f1aaf3d2dfce5ccdfbba79b1a8bbe2a703e3a6627d071ea2b2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769030403,
      "headline": "Johnson & Johnson (JNJ) Tops Q4 Earnings and Revenue Estimates",
      "id": 138199574,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Johnson & Johnson (JNJ) delivered earnings and revenue surprises of +1.05% and +1.84%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?",
      "url": "https://finnhub.io/api/news?id=5d22bb60448219f1aaf3d2dfce5ccdfbba79b1a8bbe2a703e3a6627d071ea2b2"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson (JNJ) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ...",
    "summary": "Johnson & Johnson (JNJ) reports a robust 7.1% revenue increase in Q4 2025, driven by significant gains in Oncology and MedTech, while setting optimistic guidance for 2026.",
    "url": "https://finnhub.io/api/news?id=74b33607bb49fc9cab9dc0d60bb56fc80b0a4a43170948beac28738ef6aa6eb8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769029361,
      "headline": "Johnson & Johnson (JNJ) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ...",
      "id": 138198923,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Johnson & Johnson (JNJ) reports a robust 7.1% revenue increase in Q4 2025, driven by significant gains in Oncology and MedTech, while setting optimistic guidance for 2026.",
      "url": "https://finnhub.io/api/news?id=74b33607bb49fc9cab9dc0d60bb56fc80b0a4a43170948beac28738ef6aa6eb8"
    }
  },
  {
    "ts": null,
    "headline": "Stock market today: Dow surges 550 points, S&P 500, Nasdaq jump as Trump backs off Greenland tariff threats",
    "summary": "Stocks open higher as Trump speaks in Davos, where he plans meetings on the Greenland crisis.",
    "url": "https://finnhub.io/api/news?id=70c0dc97a4cb5e93cd448f0f89f2766ed2e4766406457b7a37b5c46657ee0d67",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769029259,
      "headline": "Stock market today: Dow surges 550 points, S&P 500, Nasdaq jump as Trump backs off Greenland tariff threats",
      "id": 138198924,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Stocks open higher as Trump speaks in Davos, where he plans meetings on the Greenland crisis.",
      "url": "https://finnhub.io/api/news?id=70c0dc97a4cb5e93cd448f0f89f2766ed2e4766406457b7a37b5c46657ee0d67"
    }
  },
  {
    "ts": null,
    "headline": "Sector Update: Health Care Stocks Higher Late Afternoon",
    "summary": "Health care stocks rose late Wednesday afternoon, with the NYSE Health Care Index up 1.5% and the St",
    "url": "https://finnhub.io/api/news?id=17db234bf0915958f4a33edd981eea0dea3b5bb5d19ed6dac952ec77d6bf6903",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769028881,
      "headline": "Sector Update: Health Care Stocks Higher Late Afternoon",
      "id": 138198925,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Health care stocks rose late Wednesday afternoon, with the NYSE Health Care Index up 1.5% and the St",
      "url": "https://finnhub.io/api/news?id=17db234bf0915958f4a33edd981eea0dea3b5bb5d19ed6dac952ec77d6bf6903"
    }
  },
  {
    "ts": null,
    "headline": "Stock Market Today: S&P 500 Higher After Trump Davos News; Johnson & Johnson Slides (Live Coverage)",
    "summary": "The Dow Jones Industrial Average and other major stock indexes rose Wednesday after sinking a day earlier, with some recovery arriving after President Donald Trump's rule-out of U.S. military force to pursue Greenland.",
    "url": "https://finnhub.io/api/news?id=d3267156d6ca502483b3c367e9c707a982b0a72ef58c70c0d52dca104af94354",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769024174,
      "headline": "Stock Market Today: S&P 500 Higher After Trump Davos News; Johnson & Johnson Slides (Live Coverage)",
      "id": 138198040,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "The Dow Jones Industrial Average and other major stock indexes rose Wednesday after sinking a day earlier, with some recovery arriving after President Donald Trump's rule-out of U.S. military force to pursue Greenland.",
      "url": "https://finnhub.io/api/news?id=d3267156d6ca502483b3c367e9c707a982b0a72ef58c70c0d52dca104af94354"
    }
  },
  {
    "ts": null,
    "headline": "J&J's Guidance Wallops Views, But Boston Scientific, Medtronic Take A Toll",
    "summary": "J&J's Guidance Wallops Views, But Boston Scientific, Medtronic Take A Toll",
    "url": "https://finnhub.io/api/news?id=373830a3bc2b045435ca24c1834e7c01b96c1697aa87949aaded482f0883b5d2",
    "source": "DowJones",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769022163,
      "headline": "J&J's Guidance Wallops Views, But Boston Scientific, Medtronic Take A Toll",
      "id": 138207527,
      "image": "",
      "related": "JNJ",
      "source": "DowJones",
      "summary": "J&J's Guidance Wallops Views, But Boston Scientific, Medtronic Take A Toll",
      "url": "https://finnhub.io/api/news?id=373830a3bc2b045435ca24c1834e7c01b96c1697aa87949aaded482f0883b5d2"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson Sees 2026 Profit, Sales Beating Wall Street Forecasts",
    "summary": "Strong demand for cancer and psoriasis drugs offsets pricing deal and legal concerns.",
    "url": "https://finnhub.io/api/news?id=46ef7b59ab202e1fe397483ed63feb69cdb846dbd50482decb701eed23bfb496",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769021668,
      "headline": "Johnson & Johnson Sees 2026 Profit, Sales Beating Wall Street Forecasts",
      "id": 138198116,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Strong demand for cancer and psoriasis drugs offsets pricing deal and legal concerns.",
      "url": "https://finnhub.io/api/news?id=46ef7b59ab202e1fe397483ed63feb69cdb846dbd50482decb701eed23bfb496"
    }
  },
  {
    "ts": null,
    "headline": "Sector Update: Health Care Stocks Rise in Afternoon Trading",
    "summary": "Health care stocks rose Wednesday afternoon, with the NYSE Health Care Index up 1% and the State Str",
    "url": "https://finnhub.io/api/news?id=8181d55e856dd1ea3d49b26c0c815d265d4c3e53a52603027f303091179a4b11",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769020853,
      "headline": "Sector Update: Health Care Stocks Rise in Afternoon Trading",
      "id": 138198117,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Health care stocks rose Wednesday afternoon, with the NYSE Health Care Index up 1% and the State Str",
      "url": "https://finnhub.io/api/news?id=8181d55e856dd1ea3d49b26c0c815d265d4c3e53a52603027f303091179a4b11"
    }
  },
  {
    "ts": null,
    "headline": "Stock market today: Dow, S&P 500, Nasdaq jump as Trump says US, NATO have 'framework' of a deal for Greenland",
    "summary": "Stocks open higher as Trump speaks in Davos, where he plans meetings on the Greenland crisis.",
    "url": "https://finnhub.io/api/news?id=55d93a2fde9d1c43654d9c4466a0a4755164d7082653be9a9ecac58ee746f467",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769016811,
      "headline": "Stock market today: Dow, S&P 500, Nasdaq jump as Trump says US, NATO have 'framework' of a deal for Greenland",
      "id": 138198118,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Stocks open higher as Trump speaks in Davos, where he plans meetings on the Greenland crisis.",
      "url": "https://finnhub.io/api/news?id=55d93a2fde9d1c43654d9c4466a0a4755164d7082653be9a9ecac58ee746f467"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson Q4 Earnings Call Highlights",
    "summary": "Johnson & Johnson (NYSE:JNJ) executives highlighted what they described as a “catapult year” in 2025, pointing to strong operational sales growth, accelerating momentum in key therapeutic and device categories, and a 2026 outlook that calls for faster growth and improving margins despite continu",
    "url": "https://finnhub.io/api/news?id=0f747c838e3867638510658317eb8138ac9093e76757fb5c3fc0d466cb3f8a6d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769015673,
      "headline": "Johnson & Johnson Q4 Earnings Call Highlights",
      "id": 138197145,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Johnson & Johnson (NYSE:JNJ) executives highlighted what they described as a “catapult year” in 2025, pointing to strong operational sales growth, accelerating momentum in key therapeutic and device categories, and a 2026 outlook that calls for faster growth and improving margins despite continu",
      "url": "https://finnhub.io/api/news?id=0f747c838e3867638510658317eb8138ac9093e76757fb5c3fc0d466cb3f8a6d"
    }
  },
  {
    "ts": null,
    "headline": "MDAI: In the Blocks, Ready to Go upon Mid-Year Authorization",
    "summary": "By John Vandermosten, CFA NASDAQ:MDAI READ THE FULL MDAI RESEARCH REPORT It has now been approximately seven months since Spectral AI, Inc. (NASDAQ:MDAI) announced its De Novo marketing application to the FDA for the DeepView device. Based on historical review times and no mention of unexpected delays, we anticipate that an authorization by the FDA for the DeepView device could come mid-year. We",
    "url": "https://finnhub.io/api/news?id=7453b12e4b1c9b96e92e10235c50dbd56b6cd4bf22a0bcef474b3e31901fe281",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769014980,
      "headline": "MDAI: In the Blocks, Ready to Go upon Mid-Year Authorization",
      "id": 138199578,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "By John Vandermosten, CFA NASDAQ:MDAI READ THE FULL MDAI RESEARCH REPORT It has now been approximately seven months since Spectral AI, Inc. (NASDAQ:MDAI) announced its De Novo marketing application to the FDA for the DeepView device. Based on historical review times and no mention of unexpected delays, we anticipate that an authorization by the FDA for the DeepView device could come mid-year. We",
      "url": "https://finnhub.io/api/news?id=7453b12e4b1c9b96e92e10235c50dbd56b6cd4bf22a0bcef474b3e31901fe281"
    }
  },
  {
    "ts": null,
    "headline": "Roche's Genentech Expands Investment in North Carolina Facility to $2B",
    "summary": "Roche more than doubles Genentech's Holly Springs biomanufacturing investment to approximately $2B, boosting U.S. supply-chain resilience and metabolic drug production.",
    "url": "https://finnhub.io/api/news?id=2b2ffdddf4e8535b03b35403d7dea877f12a2e897d13b5312fca9e226597545e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769013660,
      "headline": "Roche's Genentech Expands Investment in North Carolina Facility to $2B",
      "id": 138198119,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Roche more than doubles Genentech's Holly Springs biomanufacturing investment to approximately $2B, boosting U.S. supply-chain resilience and metabolic drug production.",
      "url": "https://finnhub.io/api/news?id=2b2ffdddf4e8535b03b35403d7dea877f12a2e897d13b5312fca9e226597545e"
    }
  },
  {
    "ts": null,
    "headline": "J&J's 2026 guidance driven by 'exciting' new product story",
    "summary": "Johnson & Johnson (JNJ) topped fourth quarter revenue estimates while forecasts for full-year 2026 outpaced Wall Street expectations. Guggenheim Securities senior research analyst and managing director Vamil Divan — who has a Buy rating on J&J stock — discusses the pharmaceutical giant's outlook for 2026 and possible product headwinds and tailwinds. To watch more expert insights and analysis on the latest market action, check out more Market Catalysts.",
    "url": "https://finnhub.io/api/news?id=eff8a0b5fccaa180559620d9ce64b626fd5e41130755507dc0d5853fb4ebebf3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769013037,
      "headline": "J&J's 2026 guidance driven by 'exciting' new product story",
      "id": 138197146,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Johnson & Johnson (JNJ) topped fourth quarter revenue estimates while forecasts for full-year 2026 outpaced Wall Street expectations. Guggenheim Securities senior research analyst and managing director Vamil Divan — who has a Buy rating on J&J stock — discusses the pharmaceutical giant's outlook for 2026 and possible product headwinds and tailwinds. To watch more expert insights and analysis on the latest market action, check out more Market Catalysts.",
      "url": "https://finnhub.io/api/news?id=eff8a0b5fccaa180559620d9ce64b626fd5e41130755507dc0d5853fb4ebebf3"
    }
  },
  {
    "ts": null,
    "headline": "Top Midday Stories: Trump Says US Doesn't Want to Use Force to Acquire Greenland; Netflix Shares Fall on Low Q1 Guidance",
    "summary": "All three major US stock indexes were up in late-morning trading Wednesday after President Donald Tr",
    "url": "https://finnhub.io/api/news?id=6be914b1f84de05fc2db25792111e6955ebaab2af6b7606fdaf714dac45997e3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769012747,
      "headline": "Top Midday Stories: Trump Says US Doesn't Want to Use Force to Acquire Greenland; Netflix Shares Fall on Low Q1 Guidance",
      "id": 138197137,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "All three major US stock indexes were up in late-morning trading Wednesday after President Donald Tr",
      "url": "https://finnhub.io/api/news?id=6be914b1f84de05fc2db25792111e6955ebaab2af6b7606fdaf714dac45997e3"
    }
  },
  {
    "ts": null,
    "headline": "Stock market today: Dow, S&P 500, Nasdaq jump after brutal sell-off as Trump rules out force on Greenland",
    "summary": "Stocks open higher as Trump speaks in Davos, where he plans meetings on the Greenland crisis.",
    "url": "https://finnhub.io/api/news?id=8e6c9699a4038e84bd5a1b495d08de4a4164971d7da3de1652024dc8aa512d88",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769010595,
      "headline": "Stock market today: Dow, S&P 500, Nasdaq jump after brutal sell-off as Trump rules out force on Greenland",
      "id": 138196026,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Stocks open higher as Trump speaks in Davos, where he plans meetings on the Greenland crisis.",
      "url": "https://finnhub.io/api/news?id=8e6c9699a4038e84bd5a1b495d08de4a4164971d7da3de1652024dc8aa512d88"
    }
  },
  {
    "ts": null,
    "headline": "Wall Street Lunch: Trump Takes U-Turn On Greenland Tariffs After Reaching Arctic Framework",
    "summary": "President Donald Trump has backed off his threat to impose new tariffs in February, after negotiations in Davos over Greenland.",
    "url": "https://finnhub.io/api/news?id=1df2443b7658703317d62fdd9e48373439eba2aab25aa726eeafdc5a4198eb4b",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769010049,
      "headline": "Wall Street Lunch: Trump Takes U-Turn On Greenland Tariffs After Reaching Arctic Framework",
      "id": 138198643,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2257409203/image_2257409203.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "President Donald Trump has backed off his threat to impose new tariffs in February, after negotiations in Davos over Greenland.",
      "url": "https://finnhub.io/api/news?id=1df2443b7658703317d62fdd9e48373439eba2aab25aa726eeafdc5a4198eb4b"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson Tops Earnings Estimates and Issues a Solid Outlook. The Stock Falls.",
    "summary": "Johnson & Johnson  stock was falling even after the multinational pharmaceutical giant posted better-than-expected earnings for the fourth quarter.  The company also issued a solid full-year outlook, guiding for adjusted earnings of $11.53 a share on sales of $100.5 billion.  There was one glaring weakness in the print: Sales of Stelara, formerly one of  Johnson & Johnson’s  biggest sellers, cratered 48% in the quarter.",
    "url": "https://finnhub.io/api/news?id=c144206ed12842619d5c3bfe58639e1a68a997fa88d712de693d152314b2cb7e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769009460,
      "headline": "Johnson & Johnson Tops Earnings Estimates and Issues a Solid Outlook. The Stock Falls.",
      "id": 138197148,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Johnson & Johnson  stock was falling even after the multinational pharmaceutical giant posted better-than-expected earnings for the fourth quarter.  The company also issued a solid full-year outlook, guiding for adjusted earnings of $11.53 a share on sales of $100.5 billion.  There was one glaring weakness in the print: Sales of Stelara, formerly one of  Johnson & Johnson’s  biggest sellers, cratered 48% in the quarter.",
      "url": "https://finnhub.io/api/news?id=c144206ed12842619d5c3bfe58639e1a68a997fa88d712de693d152314b2cb7e"
    }
  },
  {
    "ts": null,
    "headline": "J&J Stock Down Despite Q4 Earnings Beat, Oncology Drugs Drive Sales",
    "summary": "JNJ beat Q4 earnings and sales estimates as strong oncology drug growth, led by Darzalex, offset biosimilar pressure on Stelara.",
    "url": "https://finnhub.io/api/news?id=c45d4690d35520567b52051b66c496e533a82b6cacad18f429dd07d5577be676",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769009280,
      "headline": "J&J Stock Down Despite Q4 Earnings Beat, Oncology Drugs Drive Sales",
      "id": 138197149,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "JNJ beat Q4 earnings and sales estimates as strong oncology drug growth, led by Darzalex, offset biosimilar pressure on Stelara.",
      "url": "https://finnhub.io/api/news?id=c45d4690d35520567b52051b66c496e533a82b6cacad18f429dd07d5577be676"
    }
  },
  {
    "ts": null,
    "headline": "GSK to Boost Respiratory & Immunology Pipeline With $2.2B RAPT Buyout",
    "summary": "GSK agrees to buy RAPT Therapeutics for $2.2B, adding ozureprubart to its pipeline and strengthening its respiratory and immunology portfolio.",
    "url": "https://finnhub.io/api/news?id=b66707b0b60542abf1a30d460a49c0f1fe4779bf3c467c2ac44bf13f1f3438f3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769008980,
      "headline": "GSK to Boost Respiratory & Immunology Pipeline With $2.2B RAPT Buyout",
      "id": 138197150,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "GSK agrees to buy RAPT Therapeutics for $2.2B, adding ozureprubart to its pipeline and strengthening its respiratory and immunology portfolio.",
      "url": "https://finnhub.io/api/news?id=b66707b0b60542abf1a30d460a49c0f1fe4779bf3c467c2ac44bf13f1f3438f3"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson Shares Fall Despite Q4 Revenue Beat",
    "summary": "Why J&J Stock Is Falling",
    "url": "https://finnhub.io/api/news?id=869bb992fe079bc89b48e5e2f31e113166907d788c7d6a79cb18b3523f30663f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769005120,
      "headline": "Johnson & Johnson Shares Fall Despite Q4 Revenue Beat",
      "id": 138196028,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Why J&J Stock Is Falling",
      "url": "https://finnhub.io/api/news?id=869bb992fe079bc89b48e5e2f31e113166907d788c7d6a79cb18b3523f30663f"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson (JNJ) Q4 2025 Earnings Call Transcript",
    "summary": "Johnson & Johnson (JNJ) Q4 2025 Earnings Call January 21, 2026 8:30 AM ESTCompany ParticipantsDarren Snellgrove - Vice President of Investor...",
    "url": "https://finnhub.io/api/news?id=2a5966954bf0bf0f369b94a096633a5f5a9c1a5a6a7e36481c43b7aaa24843f0",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769003760,
      "headline": "Johnson & Johnson (JNJ) Q4 2025 Earnings Call Transcript",
      "id": 138197833,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "Johnson & Johnson (JNJ) Q4 2025 Earnings Call January 21, 2026 8:30 AM ESTCompany ParticipantsDarren Snellgrove - Vice President of Investor...",
      "url": "https://finnhub.io/api/news?id=2a5966954bf0bf0f369b94a096633a5f5a9c1a5a6a7e36481c43b7aaa24843f0"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson Issues Upbeat 2026 Sales Outlook; Fourth-Quarter Earnings Meet Street Views",
    "summary": "Johnson & Johnson (JNJ) issued a full-year sales outlook above market expectations on Wednesday, whi",
    "url": "https://finnhub.io/api/news?id=2a741dc87a5b7973de9465baa2e2a8e104b49d1786ec92f17d25dfa8b0ffd55f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769003621,
      "headline": "Johnson & Johnson Issues Upbeat 2026 Sales Outlook; Fourth-Quarter Earnings Meet Street Views",
      "id": 138196029,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Johnson & Johnson (JNJ) issued a full-year sales outlook above market expectations on Wednesday, whi",
      "url": "https://finnhub.io/api/news?id=2a741dc87a5b7973de9465baa2e2a8e104b49d1786ec92f17d25dfa8b0ffd55f"
    }
  },
  {
    "ts": null,
    "headline": "These Stocks Are Today’s Movers: Netflix, Intel, United Airlines, Kraft Heinz, GameStop, and More",
    "summary": "Netflix shares tumble after the video streamer issues soft margin guidance, overshadowing a fourth-quarter earnings beat.",
    "url": "https://finnhub.io/api/news?id=640caa718be72385a868a76aeef094c99495990a4cb9159c8ef1f5c793948159",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768992540,
      "headline": "These Stocks Are Today’s Movers: Netflix, Intel, United Airlines, Kraft Heinz, GameStop, and More",
      "id": 138194371,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Netflix shares tumble after the video streamer issues soft margin guidance, overshadowing a fourth-quarter earnings beat.",
      "url": "https://finnhub.io/api/news?id=640caa718be72385a868a76aeef094c99495990a4cb9159c8ef1f5c793948159"
    }
  },
  {
    "ts": null,
    "headline": "Dow Jones Futures Fall With Trump's Davos Speech Due After Greenland Sell-Off; Netflix Plunges",
    "summary": "Trump will speaks at Davos after the S&P 500 and Nasdaq broke support amid his Greenland threats. Netflix plunged on earnings",
    "url": "https://finnhub.io/api/news?id=f88f8b143a5fafdddc6f4027db7465b88255b2ff93d5ff9d3b4d65453e59580e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768996559,
      "headline": "Dow Jones Futures Fall With Trump's Davos Speech Due After Greenland Sell-Off; Netflix Plunges",
      "id": 138194508,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Trump will speaks at Davos after the S&P 500 and Nasdaq broke support amid his Greenland threats. Netflix plunged on earnings",
      "url": "https://finnhub.io/api/news?id=f88f8b143a5fafdddc6f4027db7465b88255b2ff93d5ff9d3b4d65453e59580e"
    }
  },
  {
    "ts": null,
    "headline": "Earnings live: Netflix stock tumbles, Johnson & Johnson falls, Halliburton and United Airlines climb",
    "summary": "A broader set of sectors will be represented when 35 more S&P 500 companies report earnings this week, including Netflix, Procter & Gamble, and Intel.",
    "url": "https://finnhub.io/api/news?id=25f585ed10c77f4919edf9209baa0454cc5677b2f591b5e606fa77dcef37ee78",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769000293,
      "headline": "Earnings live: Netflix stock tumbles, Johnson & Johnson falls, Halliburton and United Airlines climb",
      "id": 138195099,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "A broader set of sectors will be represented when 35 more S&P 500 companies report earnings this week, including Netflix, Procter & Gamble, and Intel.",
      "url": "https://finnhub.io/api/news?id=25f585ed10c77f4919edf9209baa0454cc5677b2f591b5e606fa77dcef37ee78"
    }
  },
  {
    "ts": null,
    "headline": "Stocks making the biggest moves midday: Netflix, Teledyne, Lucid, Kraft Heinz, Intel & more",
    "summary": "Check out some of the biggest movers in midday trading.",
    "url": "https://finnhub.io/api/news?id=599e71c148679dbbc5aa6cdda0b24a9bcbb911e7d1eff37a35151a4c3387e03a",
    "source": "CNBC",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768999478,
      "headline": "Stocks making the biggest moves midday: Netflix, Teledyne, Lucid, Kraft Heinz, Intel & more",
      "id": 138205207,
      "image": "https://image.cnbcfm.com/api/v1/image/108193668-1756904885178-gettyimages-2233394867-_75a3509_yy2wi8ye.jpeg?v=1769015914&w=1920&h=1080",
      "related": "JNJ",
      "source": "CNBC",
      "summary": "Check out some of the biggest movers in midday trading.",
      "url": "https://finnhub.io/api/news?id=599e71c148679dbbc5aa6cdda0b24a9bcbb911e7d1eff37a35151a4c3387e03a"
    }
  },
  {
    "ts": null,
    "headline": "Stocks Down Pre-Bell After Recording Biggest Drop Since October",
    "summary": "US equity futures were lower on Wednesday as Wall Street digested its steepest one-day drop since Oc",
    "url": "https://finnhub.io/api/news?id=266fcd1fe05d37d84e7e712d4212137580027f8fb49241717ea3673f744fe99f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768999307,
      "headline": "Stocks Down Pre-Bell After Recording Biggest Drop Since October",
      "id": 138195100,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "US equity futures were lower on Wednesday as Wall Street digested its steepest one-day drop since Oc",
      "url": "https://finnhub.io/api/news?id=266fcd1fe05d37d84e7e712d4212137580027f8fb49241717ea3673f744fe99f"
    }
  },
  {
    "ts": null,
    "headline": "J&J’s cardiovascular business boosts medtech growth in 2025",
    "summary": "Cardiovascular was the only business unit to grow by double digits last year, helping to fuel the overall medical device business to top $33 billion.",
    "url": "https://finnhub.io/api/news?id=12231f4e3e9f1e7adadd7803488b130f814c37ba9dab233df413038dbfd9598c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768997460,
      "headline": "J&J’s cardiovascular business boosts medtech growth in 2025",
      "id": 138197151,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Cardiovascular was the only business unit to grow by double digits last year, helping to fuel the overall medical device business to top $33 billion.",
      "url": "https://finnhub.io/api/news?id=12231f4e3e9f1e7adadd7803488b130f814c37ba9dab233df413038dbfd9598c"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson Earnings Beat Estimates. The Stock Is Falling.",
    "summary": "Johnson & Johnson  stock was falling Wednesday even as the multinational pharmaceutical giant posted better-than-expected earnings for the fourth quarter.  There was one glaring weak point in the print: Sales of Stelara, formerly one of  Johnson & Johnson’s  biggest sellers, cratered 48% in the quarter.  While this partially offset operational sales growth in Johnson & Johnson’s pharmaceutical arm, sales of other products helped soften the blow.",
    "url": "https://finnhub.io/api/news?id=8883457a8f8e9f8b40cadac4fb29f8b991904b34a210fbea7ab3527886293477",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768997220,
      "headline": "Johnson & Johnson Earnings Beat Estimates. The Stock Is Falling.",
      "id": 138195101,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Johnson & Johnson  stock was falling Wednesday even as the multinational pharmaceutical giant posted better-than-expected earnings for the fourth quarter.  There was one glaring weak point in the print: Sales of Stelara, formerly one of  Johnson & Johnson’s  biggest sellers, cratered 48% in the quarter.  While this partially offset operational sales growth in Johnson & Johnson’s pharmaceutical arm, sales of other products helped soften the blow.",
      "url": "https://finnhub.io/api/news?id=8883457a8f8e9f8b40cadac4fb29f8b991904b34a210fbea7ab3527886293477"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson rounds off \"catapult year\" with profit surge",
    "summary": "Johnson & Johnson rounds off \"catapult year\" with profit surge",
    "url": "https://finnhub.io/api/news?id=5f288f05a893d5a0d8c2309d1df34e21189bb72988bef7e52437480315ed13fb",
    "source": "Fintel",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768996751,
      "headline": "Johnson & Johnson rounds off \"catapult year\" with profit surge",
      "id": 138194728,
      "image": "",
      "related": "JNJ",
      "source": "Fintel",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=5f288f05a893d5a0d8c2309d1df34e21189bb72988bef7e52437480315ed13fb"
    }
  },
  {
    "ts": null,
    "headline": "Dow Jones Futures: Trump's Davos Speech Due After Greenland Threats Trigger Sell-Off; Netflix Plunges",
    "summary": "Trump will speaks at Davos after the S&P 500 and Nasdaq broke support amid his Greenland threats. Netflix plunged on earnings",
    "url": "https://finnhub.io/api/news?id=c969e77703bd482474f368f0c56ad1cb6ef6ff7c122557bd0ed5c3d34220b361",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768996353,
      "headline": "Dow Jones Futures: Trump's Davos Speech Due After Greenland Threats Trigger Sell-Off; Netflix Plunges",
      "id": 138194296,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Trump will speaks at Davos after the S&P 500 and Nasdaq broke support amid his Greenland threats. Netflix plunged on earnings",
      "url": "https://finnhub.io/api/news?id=c969e77703bd482474f368f0c56ad1cb6ef6ff7c122557bd0ed5c3d34220b361"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson 2025 Q4 - Results - Earnings Call Presentation",
    "summary": "2026-01-21. The following slide deck was published by Johnson & Johnson in conjunction with their 2025 Q4 earnings call.",
    "url": "https://finnhub.io/api/news?id=3a9ed55ada77277f88d1a7308d868f775d2f5ee4f20fbec2de0aa4cad4c56be2",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768995067,
      "headline": "Johnson & Johnson 2025 Q4 - Results - Earnings Call Presentation",
      "id": 138196511,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "2026-01-21. The following slide deck was published by Johnson & Johnson in conjunction with their 2025 Q4 earnings call.",
      "url": "https://finnhub.io/api/news?id=3a9ed55ada77277f88d1a7308d868f775d2f5ee4f20fbec2de0aa4cad4c56be2"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson: Q4 Earnings Snapshot",
    "summary": "NEW BRUNSWICK, N.J. (AP) — Johnson & Johnson (JNJ) on Wednesday reported fourth-quarter net income of $5.12 billion. The New Brunswick, New Jersey-based company said it had net income of $2.10 per share. Earnings, adjusted for one-time gains and costs, came to $2.46 per share.",
    "url": "https://finnhub.io/api/news?id=00a7bfb93cde3207470240edf7f878930dd7e88633a9a27d852fdde8796e8bfe",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768994941,
      "headline": "Johnson & Johnson: Q4 Earnings Snapshot",
      "id": 138194350,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "NEW BRUNSWICK, N.J. (AP) — Johnson & Johnson (JNJ) on Wednesday reported fourth-quarter net income of $5.12 billion. The New Brunswick, New Jersey-based company said it had net income of $2.10 per share. Earnings, adjusted for one-time gains and costs, came to $2.46 per share.",
      "url": "https://finnhub.io/api/news?id=00a7bfb93cde3207470240edf7f878930dd7e88633a9a27d852fdde8796e8bfe"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson forecasts 2026 profit above Wall Street estimates",
    "summary": "By Michael Erman Jan 21 (Reuters) - Johnson & Johnson on Wednesday forecast 2026 sales and profit ahead of Wall Street estimates, even when including a hit of \"hundreds of millions of dollars\" from",
    "url": "https://finnhub.io/api/news?id=522515312e0dc40fe7ef792b4c2499e2acfef3eb7d8d6aded412fbf2dc314d07",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768994877,
      "headline": "Johnson & Johnson forecasts 2026 profit above Wall Street estimates",
      "id": 138194351,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "By Michael Erman Jan 21 (Reuters) - Johnson & Johnson on Wednesday forecast 2026 sales and profit ahead of Wall Street estimates, even when including a hit of \"hundreds of millions of dollars\" from",
      "url": "https://finnhub.io/api/news?id=522515312e0dc40fe7ef792b4c2499e2acfef3eb7d8d6aded412fbf2dc314d07"
    }
  },
  {
    "ts": null,
    "headline": "Genmab Announces Net Sales of DARZALEX® (daratumumab) for 2025",
    "summary": "Company Announcement Net sales of DARZALEX® in 2025 totaled USD 14,351 millionGenmab receives royalties on worldwide net sales from Johnson & Johnson (J&J, legal entity Janssen Biotech, Inc.) COPENHAGEN, Denmark; January 21, 2026 – Genmab A/S (Nasdaq: GMAB) announced today that worldwide net trade sales of DARZALEX® (daratumumab), including sales of the subcutaneous (SC) product (daratumumab and hyaluronidase-fihj, sold under the tradename DARZALEX FASPRO® in the U.S.), as reported by J&J were U",
    "url": "https://finnhub.io/api/news?id=596d6aafed5b8c805cc92b8dcfbdd48904e0fc160853729dd1c0997c0537a10f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768994580,
      "headline": "Genmab Announces Net Sales of DARZALEX® (daratumumab) for 2025",
      "id": 138194352,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Company Announcement Net sales of DARZALEX® in 2025 totaled USD 14,351 millionGenmab receives royalties on worldwide net sales from Johnson & Johnson (J&J, legal entity Janssen Biotech, Inc.) COPENHAGEN, Denmark; January 21, 2026 – Genmab A/S (Nasdaq: GMAB) announced today that worldwide net trade sales of DARZALEX® (daratumumab), including sales of the subcutaneous (SC) product (daratumumab and hyaluronidase-fihj, sold under the tradename DARZALEX FASPRO® in the U.S.), as reported by J&J were U",
      "url": "https://finnhub.io/api/news?id=596d6aafed5b8c805cc92b8dcfbdd48904e0fc160853729dd1c0997c0537a10f"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson reports Q4 and Full-Year 2025 results",
    "summary": "NEW BRUNSWICK, N.J., January 21, 2026--Johnson & Johnson (NYSE: JNJ) today announced results for fourth-quarter and full-year 2025. \"2025 was a catapult year for Johnson & Johnson, fueled by the strongest portfolio and pipeline in our history,\" said Joaquin Duato, Chairman and Chief Executive Officer, Johnson & Johnson. \"Last year kicked off a new era of accelerated growth, driven by medical innovation that is transforming lives in our six key businesses: Oncology, Immunology, Neuroscience, Card",
    "url": "https://finnhub.io/api/news?id=69043d623a0c14affee8c95c3e8a6155239bedfb98064da8eee26db3ba0bd8a1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768994400,
      "headline": "Johnson & Johnson reports Q4 and Full-Year 2025 results",
      "id": 138194355,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "NEW BRUNSWICK, N.J., January 21, 2026--Johnson & Johnson (NYSE: JNJ) today announced results for fourth-quarter and full-year 2025. \"2025 was a catapult year for Johnson & Johnson, fueled by the strongest portfolio and pipeline in our history,\" said Joaquin Duato, Chairman and Chief Executive Officer, Johnson & Johnson. \"Last year kicked off a new era of accelerated growth, driven by medical innovation that is transforming lives in our six key businesses: Oncology, Immunology, Neuroscience, Card",
      "url": "https://finnhub.io/api/news?id=69043d623a0c14affee8c95c3e8a6155239bedfb98064da8eee26db3ba0bd8a1"
    }
  },
  {
    "ts": null,
    "headline": "A Stock Slump Could Slam the Economy",
    "summary": "Yeah, right, sure—we know: “The stock market isn’t the economy.”  The share of U.S. household financial wealth derived from stocks has never been so high, easily exceeding the peak of the tech bubble.  Zooming in on who owns the lion’s share of it explains a lot about recent consumer behavior.",
    "url": "https://finnhub.io/api/news?id=84f61070af9f246a5b785e4482bc28de6c96a5780ec3e3507c88d06753401b72",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768994400,
      "headline": "A Stock Slump Could Slam the Economy",
      "id": 138194354,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Yeah, right, sure—we know: “The stock market isn’t the economy.”  The share of U.S. household financial wealth derived from stocks has never been so high, easily exceeding the peak of the tech bubble.  Zooming in on who owns the lion’s share of it explains a lot about recent consumer behavior.",
      "url": "https://finnhub.io/api/news?id=84f61070af9f246a5b785e4482bc28de6c96a5780ec3e3507c88d06753401b72"
    }
  },
  {
    "ts": null,
    "headline": "J&J’s Sales and Profit Rise on Strong Cancer and Autoimmune Drug Sales",
    "summary": "Higher sales of drugs for cancer and autoimmune conditions more than offset the sales hit from a key drug patent loss and helped  Johnson & Johnson  report increased revenue and profit for the latest quarter.  J&J said Wednesday that net earnings rose 20.8% in the fourth quarter to $5.12 billion, or $2.10 a share, from $3.43 billion, or $1.41 a share, a year earlier.  Adjusted to exclude certain items such as litigation costs, J&J earned $2.46 a share in the quarter, matching the mean estimate of analysts surveyed by Factset.",
    "url": "https://finnhub.io/api/news?id=c4029ae441d70752b17ec62d0ad626e014fb2109a7201ad3ad1a36e509153263",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768994400,
      "headline": "J&J’s Sales and Profit Rise on Strong Cancer and Autoimmune Drug Sales",
      "id": 138194353,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Higher sales of drugs for cancer and autoimmune conditions more than offset the sales hit from a key drug patent loss and helped  Johnson & Johnson  report increased revenue and profit for the latest quarter.  J&J said Wednesday that net earnings rose 20.8% in the fourth quarter to $5.12 billion, or $2.10 a share, from $3.43 billion, or $1.41 a share, a year earlier.  Adjusted to exclude certain items such as litigation costs, J&J earned $2.46 a share in the quarter, matching the mean estimate of analysts surveyed by Factset.",
      "url": "https://finnhub.io/api/news?id=c4029ae441d70752b17ec62d0ad626e014fb2109a7201ad3ad1a36e509153263"
    }
  },
  {
    "ts": null,
    "headline": "Equity Values After Sell-Offs Lift Wall Street Pre-Bell; Asia Mixed, Europe Off",
    "summary": "Wall Street futures pointed moderately higher pre-bell Wednesday as traders looked for values after",
    "url": "https://finnhub.io/api/news?id=b3a3e341dbfc86d11c45078e19c58576e3795bfd72fdda774121ef3e538a3c99",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768994106,
      "headline": "Equity Values After Sell-Offs Lift Wall Street Pre-Bell; Asia Mixed, Europe Off",
      "id": 138194356,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Wall Street futures pointed moderately higher pre-bell Wednesday as traders looked for values after",
      "url": "https://finnhub.io/api/news?id=b3a3e341dbfc86d11c45078e19c58576e3795bfd72fdda774121ef3e538a3c99"
    }
  },
  {
    "ts": null,
    "headline": "How To Earn $500 A Month From Johnson & Johnson Stock Ahead Of Q4 Earnings",
    "summary": "Johnson & Johnson (NYSE:JNJ) will release earnings for the fourth quarter before the opening bell on Wednesday, Jan. 21. Analysts expect the company to report fourth-quarter earnings of $2.47 per share. That's up from $2.04 per share in the year-ago period. The consensus estimate for Johnson & Johnson's quarterly revenue is $24.16 billion (it reported $22.52 billion last year), according to Benzinga Pro. As per the recent news, Johnson & Johnson, on Jan. 14, shared topline results from the inves",
    "url": "https://finnhub.io/api/news?id=8f79e6a67ad8238af19b1e6037af325066351a9bc00056172310fae893dc61b2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768992369,
      "headline": "How To Earn $500 A Month From Johnson & Johnson Stock Ahead Of Q4 Earnings",
      "id": 138194357,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Johnson & Johnson (NYSE:JNJ) will release earnings for the fourth quarter before the opening bell on Wednesday, Jan. 21. Analysts expect the company to report fourth-quarter earnings of $2.47 per share. That's up from $2.04 per share in the year-ago period. The consensus estimate for Johnson & Johnson's quarterly revenue is $24.16 billion (it reported $22.52 billion last year), according to Benzinga Pro. As per the recent news, Johnson & Johnson, on Jan. 14, shared topline results from the inves",
      "url": "https://finnhub.io/api/news?id=8f79e6a67ad8238af19b1e6037af325066351a9bc00056172310fae893dc61b2"
    }
  },
  {
    "ts": null,
    "headline": "J&J wants to be the leader in the cancer fight. Its strategy is starting to pay off as oncology sales top $25 billion in 2025.",
    "summary": "J&J wants to be the leader in the cancer fight. Its strategy is starting to pay off as oncology sales top $25 billion in 2025.",
    "url": "https://finnhub.io/api/news?id=cdd23fa6c1d4f63a4990914aa369157826d7609568e8e686b74a3ed69a28be92",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768990440,
      "headline": "J&J wants to be the leader in the cancer fight. Its strategy is starting to pay off as oncology sales top $25 billion in 2025.",
      "id": 138207548,
      "image": "",
      "related": "JNJ",
      "source": "MarketWatch",
      "summary": "J&J wants to be the leader in the cancer fight. Its strategy is starting to pay off as oncology sales top $25 billion in 2025.",
      "url": "https://finnhub.io/api/news?id=cdd23fa6c1d4f63a4990914aa369157826d7609568e8e686b74a3ed69a28be92"
    }
  },
  {
    "ts": null,
    "headline": "Stocks to Watch Wednesday: Netflix, United Airlines, Kraft Heinz",
    "summary": "↘️ Netflix (NFLX): The streaming company posted better-than-expected quarterly results, with series such as “Stranger Things” boosting viewership. However, shares dropped 6.5% in premarket trading. Netflix posted its results shortly after sweetening its $72 billion bid for Warner Bros.",
    "url": "https://finnhub.io/api/news?id=67c905fe80c497504181c5ea40a9f6a81a318d3137a6231b0f3fdb2f613e5b90",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768988816,
      "headline": "Stocks to Watch Wednesday: Netflix, United Airlines, Kraft Heinz",
      "id": 138194358,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "↘️ Netflix (NFLX): The streaming company posted better-than-expected quarterly results, with series such as “Stranger Things” boosting viewership. However, shares dropped 6.5% in premarket trading. Netflix posted its results shortly after sweetening its $72 billion bid for Warner Bros.",
      "url": "https://finnhub.io/api/news?id=67c905fe80c497504181c5ea40a9f6a81a318d3137a6231b0f3fdb2f613e5b90"
    }
  },
  {
    "ts": null,
    "headline": "Trump at Davos, Intel Earnings, Supreme Court: What to Watch This Week",
    "summary": "Earnings season kicked up a gear this week, with results still due from Johnson & Johnson and Intel, among other companies. Plus, President Trump is at the World Economic Forum in Davos, Switzerland, where he is due to speak on Wednesday.",
    "url": "https://finnhub.io/api/news?id=5fd00ce9a9e7ae53d50b687acaca8ce78ff8a1c19f7115fb4c2c0ea093f9a38d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768986391,
      "headline": "Trump at Davos, Intel Earnings, Supreme Court: What to Watch This Week",
      "id": 138194305,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Earnings season kicked up a gear this week, with results still due from Johnson & Johnson and Intel, among other companies. Plus, President Trump is at the World Economic Forum in Davos, Switzerland, where he is due to speak on Wednesday.",
      "url": "https://finnhub.io/api/news?id=5fd00ce9a9e7ae53d50b687acaca8ce78ff8a1c19f7115fb4c2c0ea093f9a38d"
    }
  },
  {
    "ts": null,
    "headline": "Jim Cramer's top 10 things to watch in the stock market Wednesday",
    "summary": "Stocks trended lower this morning following the market's biggest selloff in three months.",
    "url": "https://finnhub.io/api/news?id=95956307939ee4140498eb2c66f3554f02e6edde2c4ff7941ba7988394aaa7f7",
    "source": "CNBC",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768986024,
      "headline": "Jim Cramer's top 10 things to watch in the stock market Wednesday",
      "id": 138196685,
      "image": "https://image.cnbcfm.com/api/v1/image/108254359-1768925885954-gettyimages-2256686492-AFP_93DT88C.jpeg?v=1769000926&w=1920&h=1080",
      "related": "JNJ",
      "source": "CNBC",
      "summary": "Stocks trended lower this morning following the market's biggest selloff in three months. ",
      "url": "https://finnhub.io/api/news?id=95956307939ee4140498eb2c66f3554f02e6edde2c4ff7941ba7988394aaa7f7"
    }
  },
  {
    "ts": null,
    "headline": "Stocks making the biggest moves premarket: Netflix, United Airlines, Kraft Heinz & more",
    "summary": "These are the stocks posting the largest moves in premarket trading.",
    "url": "https://finnhub.io/api/news?id=2b97986eb99f49889bcc36581b50bf53e1807d07cd27436d15b67c527707b27e",
    "source": "CNBC",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768979217,
      "headline": "Stocks making the biggest moves premarket: Netflix, United Airlines, Kraft Heinz & more ",
      "id": 138196781,
      "image": "https://image.cnbcfm.com/api/v1/image/108254614-17689455512026-01-20t214313z_1884653475_rc225ja7c659_rtrmadp_0_warner-bros-discovery-m-a-netflix.jpeg?v=1768945834&w=1920&h=1080",
      "related": "JNJ",
      "source": "CNBC",
      "summary": "These are the stocks posting the largest moves in premarket trading. ",
      "url": "https://finnhub.io/api/news?id=2b97986eb99f49889bcc36581b50bf53e1807d07cd27436d15b67c527707b27e"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson headlines earnings slate",
    "summary": "Johnson & Johnson headlines earnings slate",
    "url": "https://finnhub.io/api/news?id=85a2136de2778262b1609218bb7bdf078a1f8700abff82cf39a1fd8840d25082",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768973124,
      "headline": "Johnson & Johnson headlines earnings slate",
      "id": 138207549,
      "image": "",
      "related": "JNJ",
      "source": "MarketWatch",
      "summary": "Johnson & Johnson headlines earnings slate",
      "url": "https://finnhub.io/api/news?id=85a2136de2778262b1609218bb7bdf078a1f8700abff82cf39a1fd8840d25082"
    }
  },
  {
    "ts": null,
    "headline": "Is Johnson & Johnson (JNJ) Pricing Reflect Its Cash Flow Outlook And Legal Risk News",
    "summary": "If you are wondering whether Johnson & Johnson is reasonably priced at its recent levels, you are not alone. Many investors are asking if the current share price lines up with the underlying business. The stock last closed at US$218.21, with returns of 2.1% over 7 days, 5.7% over 30 days, 5.2% year to date and 51.8% over the past year, as well as 42.0% over 3 years and 47.5% over 5 years. Recent news around Johnson & Johnson has focused on its position as a large healthcare name and ongoing...",
    "url": "https://finnhub.io/api/news?id=f0a7303d15ab86b56db35a8a60da076b81a2a380740b258869fad9454deded95",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768961466,
      "headline": "Is Johnson & Johnson (JNJ) Pricing Reflect Its Cash Flow Outlook And Legal Risk News",
      "id": 138192080,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "If you are wondering whether Johnson & Johnson is reasonably priced at its recent levels, you are not alone. Many investors are asking if the current share price lines up with the underlying business. The stock last closed at US$218.21, with returns of 2.1% over 7 days, 5.7% over 30 days, 5.2% year to date and 51.8% over the past year, as well as 42.0% over 3 years and 47.5% over 5 years. Recent news around Johnson & Johnson has focused on its position as a large healthcare name and ongoing...",
      "url": "https://finnhub.io/api/news?id=f0a7303d15ab86b56db35a8a60da076b81a2a380740b258869fad9454deded95"
    }
  },
  {
    "ts": null,
    "headline": "Review & Preview: Sell America?",
    "summary": "New geopolitical tensions spooked investors on Tuesday. Plus, the Supreme Court is set to listen to arguments for Trump v. Cook.",
    "url": "https://finnhub.io/api/news?id=0cb345f4fe07c5e72ccb12003c6b3f2675b4d5e95e6e8928e17fb9ae8aa9cc80",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768956900,
      "headline": "Review & Preview: Sell America?",
      "id": 138192081,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "New geopolitical tensions spooked investors on Tuesday. Plus, the Supreme Court is set to listen to arguments for Trump v. Cook.",
      "url": "https://finnhub.io/api/news?id=0cb345f4fe07c5e72ccb12003c6b3f2675b4d5e95e6e8928e17fb9ae8aa9cc80"
    }
  },
  {
    "ts": null,
    "headline": "Trump in Davos, SCOTUS hearing, J&J earnings: What to Watch",
    "summary": "Market Domination Overtime Host Josh Lipton previews several of the biggest stories to come tomorrow, Wednesday, January 21, including President Trump's speech at the World Economic Forum (WEF) in Davos, Switzerland, the US Supreme Court (SCOTUS) hearing on whether the administration has the ability to fire Federal Reserve governor Lisa Cook, US pending homes sales, and quarterly earnings reports from companies like Johnson & Johnson (JNJ), Charles Schwab (SCHW), and Haliburton (HAL). To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime.",
    "url": "https://finnhub.io/api/news?id=9ab7676e2bc8bb908f2a66fe0592dea083b4dcd17815e0b1f31e45b0d70000a5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768953625,
      "headline": "Trump in Davos, SCOTUS hearing, J&J earnings: What to Watch",
      "id": 138191044,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Market Domination Overtime Host Josh Lipton previews several of the biggest stories to come tomorrow, Wednesday, January 21, including President Trump's speech at the World Economic Forum (WEF) in Davos, Switzerland, the US Supreme Court (SCOTUS) hearing on whether the administration has the ability to fire Federal Reserve governor Lisa Cook, US pending homes sales, and quarterly earnings reports from companies like Johnson & Johnson (JNJ), Charles Schwab (SCHW), and Haliburton (HAL). To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime.",
      "url": "https://finnhub.io/api/news?id=9ab7676e2bc8bb908f2a66fe0592dea083b4dcd17815e0b1f31e45b0d70000a5"
    }
  }
]